Lisziewicz Julianna, Lori Franco
Research Institute for Genetic and Human Therapy, 2233 Wisconsin Ave, NW, Suite 503, Washington, DC 20007, USA.
Expert Opin Biol Ther. 2003 Jul;3(4):683-7. doi: 10.1517/14712598.3.4.683.
The 2nd International Symposium on Molecular Diagnostics and Skin Gene Therapy was held on a beautiful spring weekend at one of the youngest universities in the world, the Heinrich-Heine University, founded 1965. The conference attracted more than 340 participants from 24 different countries, including ethicists, basic researchers, virologists, immunologists, molecular biologists and clinicians, as well as numerous students. The event was organised under the auspices of the European Gene Therapy Society by U Hengge of the Department of Dermatology at Heinrich-Heine University. As Dr J Glorioso, President of the American Society for Gene Therapy, pointed out in his welcome address, the skin is a new target for gene therapy, with the potential for in vivo gene transfer to the central nervous system or to the lymphoid organs, for example. As such, Düsseldorf was a perfect location for such a meeting, because the most important biomedical research investments in Germany have been in neurology and dermatology. Many scientific challenges facing this young field of medicine were presented, but there was also much discussion of ethical, regulatory and safety issues with respect to gene therapy.
第二届分子诊断与皮肤基因治疗国际研讨会于一个美丽的春日周末在世界上最年轻的大学之一——1965年成立的海因里希·海涅大学举行。会议吸引了来自24个不同国家的340多名与会者，包括伦理学家、基础研究人员、病毒学家、免疫学家、分子生物学家和临床医生，以及众多学生。该活动由海因里希·海涅大学皮肤科的U Hengge在欧洲基因治疗协会的主持下组织。正如美国基因治疗协会主席J Glorioso博士在欢迎辞中所指出的，皮肤是基因治疗的一个新靶点，例如有可能将体内基因转移到中枢神经系统或淋巴器官。因此，杜塞尔多夫是举办这样一次会议的理想地点，因为德国最重要的生物医学研究投资都集中在神经学和皮肤病学领域。会议提出了这个年轻医学领域面临的许多科学挑战，但也对基因治疗的伦理、监管和安全问题进行了大量讨论。
